![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Eirx Therap. | LSE:ERX | London | Ordinary Share | GB00B0XQBS97 | ORD 0.001P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.015 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
RNS Number : 9020W EiRx Therapeutics PLC 17 June 2008 EIRX THERAPEUTICS PLC ("the Company") 17 June 2008 Result of Extraordinary General Meeting At the Extraordinary General Meeting of the Company held earlier today, all resolutions were passed. For further information, please contact: EiRx Therapeutics plc +353 (0)21 432 0847 Colin Telfer PhD, Chief Executive Officer Grant Thornton Corporate Finance +44 (0)20 7383 5100 Philip Secrett / Colin Aaronson This information is provided by RNS The company news service from the London Stock Exchange END REGSFIFFWSASEFM
1 Year Eirx Therapeutics Chart |
1 Month Eirx Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions